$SRPT News Article - Sarepta Therapeutics Announce
Post# of 58
(Total Views: 313)
Posted On: 08/25/2020 2:35:51 PM
$SRPT News Article - Sarepta Therapeutics Announces FDA Acceptance of Casimersen (SRP-4045) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 45 https://marketwirenews.com/news-releases/sare...14793.html
(0)
(0)Sarepta Therapeutics Inc. (SRPT) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼